An intron variant in the neighboring BCL2 gene has been associated with prostate carcinoma in two GWASs with P-values < 5.0 × 10−8 (47, 48), but no cancer associations have been reported for either PHLPP1 or PHLPP2 (SI Appendix, Fig. S7 C and D). This evidence concerns the gene BCL2 and prostate carcinoma.